What is the official ID of this bill?

The official print number for this legislation is S 298.

When did the legislative process begin?

The process officially started on 2021-02-08.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/s298/BILLS-117s298is.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Who is the primary sponsor?

The primary sponsor is Sen. Blackburn, Marsha [R-TN].

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Analysis and Potential Impact of S 298

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Study on Pharmacy Benefit Managers: Lowering Drug Costs for Citizens

Q: What are the main provisions?

Key points include: Investigating how PBMs affect drug prices and whether they favor more expensive drugs with higher rebates. Analyzing how much of drug rebates go to patients versus how much PBMs retain. Developing recommendations for Congress to lower prescription drug costs and increase market competition.

This act aims to study how Pharmacy Benefit Managers (PBMs) operate, as they influence drug prices. The goal is to understand their role in the supply chain, competition among them, and how they manage rebates and fees. The study's findings are intended to help lower prescription drug costs for patients and improve market transparency.

Key points

Investigating how PBMs affect drug prices and whether they favor more expensive drugs with higher rebates.

Analyzing how much of drug rebates go to patients versus how much PBMs retain.

Developing recommendations for Congress to lower prescription drug costs and increase market competition.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Pharmacy Benefit Manager Accountability Study Act of 2021

Print number: S 298

Sponsor: Sen. Blackburn, Marsha [R-TN]

Process start date: 2021-02-08

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Study on Pharmacy Benefit Managers: Lowering Drug Costs for Citizens

Key Questions about Study on Pharmacy Benefit Managers: Lowering Drug Costs for Citizens